- Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
-
Banerjee R, Raja Ali RA, Wei SC, Adsul S
- KMID: 2508688
- Gut Liver.
- 2020 Nov;14(6):685-698.
- doi: 10.5009/gnl19209
The advent of biologics and biologic therapy has transformed the management of inflammatory bowel disease (IBD) with enhanced early and adequate responses to treatment, fewer hospitalizations, a reduced need for... -
- CITED
-
- Close
- SHARE
-
- Close
- Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
-
Ooi CJ, Hilmi I, Banerjee R, Chuah SW, Ng SC, Wei SC, Makharia G, Pisespongsa P, Chen MH, Ran ZH, Ye BD, Park DI, Ling KL, Ong D, Ahuja V, Goh KL, Sollano J, Lim WC, Leung WK, Ali RA, Wu DC, Ong E, Mustaffa N, Limsrivilai J, Hisamatsu , Yang SK, Ouyang Q, Geary R, De Silva J, Rerknimitr R, Simadibrata M, Abdullah M, Leong RW, on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn's and Colitis
- KMID: 2454738
- Intest Res.
- 2019 Jul;17(3):285-310.
- doi: 10.5217/ir.2019.00026
The Asia-Pacific Working Group on inflammatory bowel disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology with the goal of improving IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
-
Yen HH, Weng MT, Tung CC, Wang YT, Chang YT, Chang CH, Shieh MJ, Wong JM, Wei SC
- KMID: 2438443
- Intest Res.
- 2019 Jan;17(1):54-62.
- doi: 10.5217/ir.2018.00096
BACKGROUND/AIMS: Incidences of inflammatory bowel disease (IBD), ulcerative colitis (UC), and Crohn’s disease (CD), have been increasing in Asia. In this study, we report the relevant clinical characteristics and determined... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of microbiota in colorectal carcinogenesis: lessons from experimental models
-
Yu LC, Wei SC, Ni YH
- KMID: 2417646
- Intest Res.
- 2018 Jul;16(3):346-357.
- doi: 10.5217/ir.2018.16.3.346
A role of gut microbiota in colorectal cancer (CRC) growth was first suggested in germ-free rats almost 50 years ago, and the existence of disease-associated bacteria (termed pathobionts) had becoming... -
- CITED
-
- Close
- SHARE
-
- Close
- Should Asian inflammatory bowel disease patients need routine thromboprophylaxis?
-
Weng MT, Tung CC, Wong JM, Wei SC
- KMID: 2417685
- Intest Res.
- 2018 Apr;16(2):312-314.
- doi: 10.5217/ir.2018.16.2.312
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
-
Wei SC, Tung CC, Weng MT, Wong JM
- KMID: 2434156
- Intest Res.
- 2018 Oct;16(4):546-553.
- doi: 10.5217/ir.2018.00052
BACKGROUND/AIMS: Fecal calprotectin (fC) level is a predictive marker of mucosal healing for patients with inflammatory bowel disease (IBD). Home fC tests are now available. We evaluated the performance of... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
-
Park DI, Hisamatsu , Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK
- KMID: 2402643
- Intest Res.
- 2018 Jan;16(1):17-25.
- doi: 10.5217/ir.2018.16.1.17
Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
-
Park DI, Hisamatsu , Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK
- KMID: 2402642
- Intest Res.
- 2018 Jan;16(1):4-16.
- doi: 10.5217/ir.2018.16.1.4
Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in... -
- CITED
-
- Close
- SHARE
-
- Close
- Balloon-Assisted Enteroscopy and Capsule Endoscopy in Suspected Small Bowel Crohn's Disease
-
Yen HH, Chang CW, Chou JW, Wei SC
- KMID: 2394740
- Clin Endosc.
- 2017 Sep;50(5):417-423.
- doi: 10.5946/ce.2017.142
Inflammatory bowel diseases are idiopathic inflammatory diseases of two main types, Crohn's disease and ulcerative colitis. Crohn's disease can affect the entire gastrointestinal tract, and the distal ileum is involved... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
-
Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM
- KMID: 2382373
- Intest Res.
- 2017 Jul;15(3):285-310.
- doi: 10.5217/ir.2017.15.3.285
Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
-
Wei SC, Chang TA, Chao TH, Chen JS, Chou JW, Chou YH, Chuang CH, Hsu WH, Huang TY, Hsu TC, Lin CC, Lin HH, Lin JK, Lin WC, Ni YH, Shieh MJ, Shih IL, Shun CT, Tsang YM, Wang CY, Wang HY, Weng MT, Wu DC, Wu WC, Yen HH, Wong JM
- KMID: 2382372
- Intest Res.
- 2017 Jul;15(3):266-284.
- doi: 10.5217/ir.2017.15.3.266
Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study
-
Lin WC, Chou JW, Yen HH, Hsu WH, Lin HH, Lin JK, Chuang CH, Huang TY, Wang HY, Wei SC, Wong JM
- KMID: 2396398
- Intest Res.
- 2017 Oct;15(4):487-494.
- doi: 10.5217/ir.2017.15.4.487
BACKGROUND/AIMS: In Taiwan, due to budget limitations, the National Health Insurance only allows for a limited period of biologics use in treating moderate to severe Crohn's disease (CD). We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Polypoid lesions at the anal canal: what do they hint?
-
Wei SC, Lin BR, Shun CT, Wong JM
- KMID: 2368499
- Intest Res.
- 2017 Jan;15(1):142-143.
- doi: 10.5217/ir.2017.15.1.142
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A retrospective analysis of 20-year data of the surgical management of ulcerative colitis patients in Taiwan: a study of Taiwan Society of Inflammatory Bowel Disease
-
Lin CC, Wei SC, Lin BR, Tsai WS, Chen JS, Hsu TC, Lin WC, Huang TY, Chao TH, Lin HH, Wong JM, Lin JK
- KMID: 2354967
- Intest Res.
- 2016 Jul;14(3):248-257.
- doi: 10.5217/ir.2016.14.3.248
BACKGROUND/AIMS: With the recent progress in medical treatment, surgery still plays a necessary and important role in treating ulcerative colitis (UC) patients. In this study, we analyzed the surgical results... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries
-
Wei SC
- KMID: 2354963
- Intest Res.
- 2016 Jul;14(3):218-223.
- doi: 10.5217/ir.2016.14.3.218
BACKGROUND/AIMS: The cost of caring for patients with inflammatory bowel disease (IBD) is high. Without government support, the cost burden will unavoidably rest on the patients and their family. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
-
Wei SC
- KMID: 2354945
- Intest Res.
- 2016 Oct;14(4):293-294.
- doi: 10.5217/ir.2016.14.4.293
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Intestinal Stricture in Crohn's Disease
-
Chang CW, Wong JM, Tung CC, Shih IL, Wang HY, Wei SC
- KMID: 1807373
- Intest Res.
- 2015 Jan;13(1):19-26.
- doi: 10.5217/ir.2015.13.1.19
Crohn's disease (CD) is a disease with chronic inflammation of unknown etiology involving any part of the gastrointestinal tract. The incidence and prevalence of CD are increasing recently in Asia.... -
- CITED
-
- Close
- SHARE
-
- Close
- Seminar Report From the 2014 Taiwan Society of Inflammatory Bowel Disease (TSIBD) Spring Forum (May 24th, 2014): Crohn's Disease Versus Intestinal Tuberculosis Infection
-
Weng MT, Wei SC, Lin CC, Tsang YM, Shun CT, Wang JY, Shieh MJ, Wang CY, Wong JM
- KMID: 1807371
- Intest Res.
- 2015 Jan;13(1):6-10.
- doi: 10.5217/ir.2015.13.1.6
Since Taiwan is an endemic area for tuberculosis (TB), differential diagnosis between the intestinal TB and Crohn's disease is an important issue. The steering committee of Taiwan Society of Inflammatory... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study
-
Chang CW, Wei SC, Chou JW, Hsu TC, Chuang CH, Lin CP, Hsu WH, Yen HH, Lin JK, Fang YJ, Wang HY, Lin HH, Wu DC, Ni YH, Wang CY, Wong JM
- KMID: 2174405
- Intest Res.
- 2014 Oct;12(4):287-292.
- doi: 10.5217/ir.2014.12.4.287
BACKGROUND/AIMS: Only moderate to severe Crohn's Disease (CD) patients without a satisfactory conventional therapy effect are eligible to get reimbursement from the National Health Insurance of Taiwan for using adalimumab.... -
- CITED
-
- Close
- SHARE
-
- Close
- Crohn's Disease Complicated with Duodenocolic Fistula: A Case Report
-
Weng MT, Wei SC, Tien YW, Shih IL, Wong JM
- KMID: 2284918
- Intest Res.
- 2013 Oct;11(4):299-302.
- doi: 10.5217/ir.2013.11.4.299
Fistula formation is common during the course of Crohn's disease, whereas duodenocolic fistulas are very rare. The management of internal fistulas in Crohn's disease is a complex issue. Herein, we... -
- CITED
-
- Close
- SHARE
-
- Close
